Ptc Therapeuticsincis A Global Biopharmaceutical Company Based In South Plainfieldnew Jerseyfocused On Developing Therapies For Rare Diseasesfounded In 1998Ptc Is Dedicated To Creating Innovative Treatments Through Advanced Science And Technologythe Company Operates In The Us And Europeemphasizing A Patient Centric Approach To Provide Access To Effective Therapies For Individuals With Limited Treatment Options Ptc Therapeutics Invests Significantly In Research And Developmentexploring Post Translational Control Mechanisms And Rna Mechanisms To Discover New Treatmentsthe Company Conducts Clinical Trials To Advance Its Pipeline And Collaborates With Other Biotechnology And Pharmaceutical Companies To Enhance Its Drug Development Effortsptc S Marketed Products Include Evrysdi For Spinal Muscular Atrophy And Translarna And Emflaza For Duchenne Muscular Dystrophythe Company Is Also Developing Pipeline Candidates Like Ptc518 For Huntingtonae S Disease And Cnsa 001 For Orphan Metabolic Diseases
No conferences found for this company.
| Company Name | Censa Pharmaceuticals Australia Pty Ltd |
| Country |
Australia
|
| Address | N/A |
| Telephone | N/A |
| N/A |
